http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002300885-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c00fdff8c4e71e8bfff738481f4e3145 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate | 2001-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81c38e4d3513395194483e52657f6c52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55975f0e72c805c45c459621258d9324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_681c5c60a37fd03d2808ca0fb2100e79 |
publicationDate | 2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002300885-A |
titleOfInvention | Nucleic acid ligands that specifically bind to translation initiation factors |
abstract | (57) [Summary] (with correction) [PROBLEMS] To provide a substance that can be used for elucidating, diagnosing, and treating the onset mechanism of a disease caused by translation abnormality. SOLUTION: It has a base sequence which can specifically bind to a translation initiation factor, for example, human translation initiation factor eIF4A1, etc., has a base sequence selected from the group consisting of a specific sequence, and a mutation is inserted into the base sequence. A labeled RNA abtamer in which at least one base in the sequence has been modified. Further, a method for detecting and / or quantifying a translation initiation factor using the above RNA abtamer. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2007004748-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637656-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4910195-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007004748-A1 |
priorityDate | 2001-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.